Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings

Reproductive BioMedicine Online

Volumn 13, Issue 5, 2006, Pages 712-724

  Grinnemo, Karl Henrik ^a   Kumagai Braesch, Makiko ^a   Månsson Broberg, Agneta ^a   Skottman, Heli ^b   Hao, Xiaojin ^a   Siddiqui, Anwar ^a   Andersson, Agneta ^a   Strömberg, Anne Marie ^a   Lahesmaa, Riita ^c   Hovatta, Outi ^a,b   Sylven, Christer ^a   Corbascio, Matthias ^d   Dellgren, Göran ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c TURKU CENTRE FOR BIOTECHNOLOGY   (Finland)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Human embryonic stem cells; T cell proliferation and rejection; Transplantation

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ACUTE GRAFT REJECTION; ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CELL SURFACE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DNA MICROARRAY; EMBRYO; EMBRYONIC STEM CELL; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOCOMPETENCE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE CULTURE; LYMPHOCYTIC INFILTRATION; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; WILD TYPE; XENOTRANSPLANTATION;

EID: 33751095694     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60663-3     Document Type: Article

References (20)

1. Amit M, Carpenter MK, Inokuma MS et al. 2000 Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Developmental Biology 227, 271-278.
2. Bradley JA, Bolton EM, Pedersen RA. 2002 Stem cell medicine encounters the immune system. Nature Reviews Immunology 2, 859-871.
3. Draper JS, Pigott C, Thomson JA et al. 2002 Surface antigens of human embryonic stem cells: changes upon differentiation in culture. Journal of Anatomy 200, 249-258.
4. Drukker M, Katchman H, Katz G et al. 2006 Human embryonic stem cells and their differentiated derivatives are less susceptible for immune rejection than adult cells. Stem Cells 24, 221-229.
5. Drukker M, Katz G, Urbach A et al. 2002 Characterization of the expression of MHC proteins in human embryonic stem cells. Proceedings of the National Academy of Sciences of the USA 99, 9864-9869.
6. Fandrich F, Lin X, Chai GX et al. 2002 Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nature Medicine 8, 171-178.
7. Gertow K, Wolbank S, Rozell B et al. 2004 Organised development from human embryonic stem cells after injection into immunodeficient mice. Stem Cells and Development 13, 421-435.
8. Grinnemo KH, Mansson A, Dellgren G et al. 2004 Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. Journal of Thoracic and Cardiovascular Surgery 127, 1293-1300.
9. Hamad AR, Schneck JP 2001 Antigen-induced T cell death is regulated by CD4 expression. International Reviews of Immunology 20, 535-546.
10. Heins N, Englund MCO, Sjöblom C et al. 2004 Derivation, characterization, and differentiation of human embryonic stem cells. Stem Cells 22, 367-376.
11. Hovatta O, Mikkola M, Gertow K et al. 2003 A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Human Reproduction 18, 1404-1409.
12. Inzunza J, Gertow K, Stromberg MA et al. 2005 Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. Stem Cells 23, 544-549.
13. Itskovitz-Eldor J, Schuldiner M, Karsenti D et al. 2000 Differentiation of human embryonic stem cells into embryoid bodies comprising the three embryonic germ layers. Molecular Medicine 6, 88-95.
14. Koivisto H, Hyvarinen M, Stromberg AM et al. 2004 Cultures of human embryonic stem cells: serum replacement medium or serum-containing media and the effect of basic fibroblast growth factor. Reproductive BioMedicine Online 9, 330-337.
15. Larsson LC, Corbascio M, Pearson TC et al. 2003 Induction of operational tolerance to discordant dopaminergic porcine xenografts. Transplantation 75, 1448-1454.
16. Li L, Baroja ML, Majumdar A et al. 2004 Human embryonic stem cells possess immune-privileged properties. Stem Cells 22, 448-456.
17. Reubinoff BE, Pera MF, Fong CY et al. 2000 Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nature Biotechnology 18, 399-404.
18. Roncarolo MG, Bacchetta R, Bordignon C et al. 2001 Type 1 T regulatory cells. Immunological Reviews 182, 68-79.
19. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. 1998 Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
20. Xu C, Inokuma MS, Denham J et al. 2001 Feeder-free growth of undifferentiated human embryonic stem cells. Nature Biotechnology 19, 971-974.